Identifying genuinely effective treatments to prevent and reverse human age-related disease
Longevity Escape Velocity (LEV) Foundation exists to proactively identify and address the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease.
LEVF is a non-profit organisation, currently a project of the Ichor Research Institute.
LEV Foundation's core team is dedicated to the task of identifying and resolving obstacles to the urgent development and clinical translation of damage-repair therapies for human age-related disease. Our work is supported by our Board of Directors, who bring extensive experience in organizational management and an unbreakable commitment to honor donor intent.
LEV Foundation Executive Team
• Aubrey de Grey, President and CSO
• Caitlin Lewis
• Ben Zealley
• Maximus Peto
LEV Foundation Board of Directors
• Greg Grinberg, Executive Chair
• Daria Khaltourina, Board Member
• Martin O'Dea, Board Member and Events Director
• Gennady Stolyarov, Board Member
• David Wood, Board Member
LEV Foundation Advisors
• Pat Nicklin
Visit website: https://www.levf.org/
Mentioned in this Resource
Founding Member of International Longevity Alliance. Promoted aging as an ICD11 disease as WHO
Gennady Stolyarov II
Author, philosopher, composer, futurist, and actuary - known for Death is Wrong
LEV Foundation News
Lifespan.io talks to Aubrey de Grey to find out more about LEVF's Robust Mouse Rejuvenation project
Lifespan.io (LEAF) - 10-Jan-2023
Round 1 testing rapamycin, senolytic, HSCT & mTERT - could start seeing interesting results within 6 monthsRead more...